Jan 07 2025 38 mins 3
How are weight loss medications, like Ozempic, reshaping obstructive sleep apnea care? In this episode of the BackTable ENT podcast, host Dr. Gopi Shah discusses emerging weight loss medications and their impact on obstructive sleep apnea (OSA) with Dr. John Carter, a neurologist and sleep specialist, and Dr. Michael Weber, an otolaryngologist.
---
SYNPOSIS
The doctors examine optimal candidates for GLP-1 medications, their side effects, and how these drugs integrate into current OSA treatment pathways. The conversation delves into patients’ experiences, new research findings, and the implications for future sleep apnea management and weight loss strategies. In sum, the episode highlights the promising role of GLP-1 medications while addressing potential challenges and unanswered questions.
---
TIMESTAMPS
00:00 - Introduction
03:06 - Understanding Weight Loss Medications
06:18 - Impact of Weight Loss on OSA
12:56 - Clinical Trials and Research
18:57 - Future of OSA Management
23:19 - Challenges and Considerations
29:27 - Pediatric Considerations
37:05 - Final Thoughts and Contact Information
---
RESOURCES
Dr. John Carter Profile
https://www.metrohealth.org/physician/john-carter-176808
Dr. Michael Weber
https://www.metrohealth.org/physician/michael-weber-174663
BackTable+ for ENT
https://plus.backtable.com/pages/ent
Check out BackTable+ for ENT, our sponsor and new e-learning platform! https://plus.backtable.com/pages/ent
